School of Medicine

People taking TNF inhibitors, a kind of immunosuppressive drug used to treat rheumatoid arthritis and other autoimmune conditions, produced a weaker and shorter-lived antibody response after two doses of Pfizer’s COVID-19 vaccine, according to a study from Washington University School of Medicine.

Brian N. Finck, professor of medicine at the School of Medicine, received a four-year $1.7 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) for research on nonalcoholic fatty liver disease.

Daniel Kreisel, surgical director of lung transplantation at Washington University School of Medicine and Barnes-Jewish Hospital, is a principal investigator in a clinical trial funded with a $22 million grant from the National Institutes of Health (NIH). The trial aims to reduce lung transplant rejection.

Research from the lab of Deanna Barch shows that youth who indicate they have persistent, distressing psychotic-like episodes show impairment in a variety of areas.

The Brown School, the Institute for Public Health’s Center for Dissemination and Implementation and the School of Medicine’s Infectious Disease Division have launched the Infectious Disease Dissemination and Implementation Science (IDDI) Initiative.

Michael L. Gross, professor in Arts & Sciences and at the School of Medicine, received a $31,500 subcontract from GenNext to support their NIH-funded project.

Denise E. Wilfley, professor at the School of Medicine and in Arts & Sciences, received a five-year $2.6 million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) for a training program in obesity and cardiovascular disease.

A multidisciplinary team of researchers at Washington University is developing a machine-learning-based early warning system to predict cancer patients’ deterioration and improve patient outcomes.

Ramsey Hachem, the Tracey C. Marshall – Dr. Elbert P. Trulock Distinguished Professor of Medicine at the School of Medicine, received a $2.2 million research grant from the Cystic Fibrosis Foundation.

Jennifer K. Lodge, vice chancellor for research at Washington University and the David T. Blasingame Professor, will leave the university at the end of the year. Lodge will be joining Duke University as vice president for research and innovation in January.